Existing investors Legend Capital, Lilly Asia Ventures and Taikang Insurance all took part as the drug developer took its total funding to more than $530m.

Harvard University has spun out NuProbe to commercialise a molecular blood test based on research by Peng Yin and David Zhang at the Wyss Institute.

Wuxi AppTec Corporate Ventures has participated in a round that will support development of NuProbe's molecular blood test.

Corvidia's series B round has been backed by Fresenius Medial Care and AstraZeneca as its kidney disease treatment nears the end of a phase 2 trial.

Omniscient has developed a dual-view endoscope for conducting colonoscopies that could detect pre-cancerous growths currently missed by front-facing devices.

Qualcomm Ventures returned to back the virtual helathcare platform's series C round, bringing its overall funding to $160m.

MedTech Super Connector becomes the latest multi-university scheme to secure CCF funds, this time to build a UK medtech hub that encourages researchers to commercialise their ideas.